Daily Program
- Current Page
- Scientific Program > Daily Program
Sep 25 (Fri), 2020
| Sep 25 (Fri), 2020 | |||
|---|---|---|---|
| Room A | |||
| 09:10-10:40 | IJHF Special Session | 최동주 | |
| 09:10-09:30 | What a Journal Editor Is Really Looking For | Andrew Coats (the Founder & Former Editor in Chief of IJC, UK) |
|
| 09:30-09:50 | How to Cooperate between CV Journals? | 홍그루 (KCJ Deputy Editor) | |
| 09:50-10:10 | 학술지 발전경험 | 김종성 (Editor in Chief of JoS) | |
| 10:10-10:25 | 대한심부전학회지(IJHF) 발간 1년 | 박성미 (Editor in Chief of IJHF) | |
| 10:25-10:40 | Discussion | 김성환, 정욱진 | |
| 10:50-11:00 | |||
| 11:00-12:00 | HF and Kidney Disease: How to Manage both Heart and Kidney Well? | 강석민 | |
| 11:00-11:15 | Renal Replacement Therapy for HF Patient (When and How?) | 이정환 (서울의대 신장내과) | |
| 11:15-11:30 | Guideline Directed Medical Therapy for HF Patients with Renal Failure | 최성훈 (한림의대) | |
| 11:30-11:45 | How to Prevent Renal Complications during Diagnostic and Therapeutic Procedures for HF | 박혜인 (한림의대 신장내과) | |
| 11:45-12:00 | Discussion | 공민규, 정혜문 | |
| 12:05-12:55 | Scientific Session (I) - Chong Kun Dang | 김두일 | |
| 12:05-12:30 | Carvedilol: Beta Blockade & Beyond (Antiarrhythmic effect) | 최종일 (고려의대) | |
| 12:30-12:55 | Recent Update in Oral Anticoagulation Therapy | 오재원 (연세의대) | |
| 13:00-14:20 | [English Session] Cardiometabolic Disorders in HF (I) |
Kwang-Kon Koh (Korea), Jae-Hyeong Park (Korea) |
|
| 13:00-13:15 | HF and Diabetes: What Is the Goal of Treatment? | Gerasimos Filippatos (National and Kapodistrian University, of Athens, Greece) |
|
| 13:15-13:30 | Current Management of HF and T2DM with Clinical Implication from Outcome Trial | Kyung-Hee Kim (Mediplex Sejong Hospital, Korea) |
|
| 13:30-13:45 | The Association between Obesity Degree, Glycemic Status and Risk of Heart Failure | Eun-Jung Rhee (Sungkyunkwan Univ., Korea) |
|
| 13:45-14:00 | Renal Considerations in Treatment of Diabetes in HF | Eun-Sil Koh (Catholic Univ., Korea) |
|
| 14:00-14:20 | Discussion | Hyun-Jai Cho, Seong-hoon Choi | |
| 14:20-15:00 | |||
| 15:00-16:20 | [English Session] SNS and HF |
Mi-Seung Shin (Korea) | |
| 15:00-15:15 | SNS in HF: Translational View | Sung-Hea Kim (Konkuk Univ., Korea) |
|
| 15:15-15:30 | Medications for SNS in HF | Murray Esler (Monash Univ., Australia) |
|
| 15:30-15:45 | Clinical Implication of HR Reduction in HF | Jin-Joo Park (Seoul National Univ,. Korea) |
|
| 15:45-16:00 | New Perspective beyond SNS, Other Way to Go | Christoph Maack (University Clinic Würzburg, Germany) |
|
| 16:00-16:20 | Discussion | Jong-Young Lee | |
| 16:25-17:45 | The Basic Cardiac Catheterization | 홍석근 | |
| 16:25-16:40 | Indications and Interpretation | 유승기 (을지의대) | |
| 16:40-16:55 | Cardiac Catheterization in Constrictive Pericarditis and HCMP | 박준빈 (서울의대) | |
| 16:55-17:10 | Right Heart Catheterization in Patients with Pulmonary Hypertension | 황석재 (경상의대) | |
| 17:10-17:25 | Right Heart Catheterization in Patients with Advanced HF | 이수용 (부산의대) | |
| 17:25-17:45 | Discussion | 양정훈, 윤현주 | |
| Room B | |||
|---|---|---|---|
| 12:05-12:55 | Scientific Session (II)- Servier | 주승재 | |
| 12:05-12:35 | How to Keep the HF Patients Out of the Hospital with Ivabradine | Christoph Maack (University Clinic Würzburg, Germany) |
|
| 12:35-12:55 | Early Initiation of Ivabradine to Make HF Patients Live Better, Live Longer | 박진주 (서울의대) | |
| 13:00-14:20 | [English Session] Dx and Tx of HFpEF |
Seok-Min Kang (Korea) | |
| 13:00-13:15 | What's New? ESC Consensus on HFpEF Diagnosis | Jae-Won Oh (Yonsei Univ., Korea) |
|
| 13:15-13:30 | Diagnostic Values and Prognostic Impact of Temporal LV Structures Changes in HFpEF | Yasuhiko Sakata (Tohoku Univ., Japan) |
|
| 13:30-13:45 | Exercise Hemodynamics for the Diagnosis of HFpEF | Seok-Jae Hwang (Gyeonsang National Univ., Korea) |
|
| 13:45-14:00 | Ongoing Clinical Trials in HFpEF | Seong-Mi Park (Korea Univ., Korea) |
|
| 14:00-14:20 | Discussion | Sang-Ho Jo, Jung-Woo Son | |
| 14:20-15:00 | |||
| 15:00-16:20 | [English Session] [Joint Session with KHRS] Remote Monitoring for Patients with HF and Arrhythmia |
Dong-Ju Choi (Korea), Yong-Seog Oh (Korea) |
|
| 15:00-15:15 | Remote Monitoring in HF | Chan-Joo Lee (Yonsei Univ., Korea) |
|
| 15:15-15:30 | Pilot Project for Heart Failure Monitoring | Sung-Kee Ryu (Eulji Univ., Korea) |
|
| 15:30-15:45 | Monitoring of Patients Using CIED | Ji-Hyun Lee (Seoul National Univ., Korea) |
|
| 15:45-16:00 | Wearables in Patients with Arrhythmia | Jong-Il Choi (Korea Univ., Korea) |
|
| 16:00-16:20 | Discussion | Ik-Sung Cho, Jae-Sun Uhm | |
| 16:25-17:45 | [Joint Session with Artifical Intelligence] AI, Friends or Enemy? |
이승룡 | |
| 16:25-16:40 | Artificial Intelligence for Valvular Heart Disease, Quest for Precision | 이승표 (서울의대) | |
| 16:40-16:55 | Re-classification of HF with AI (Topological Approach) | 조정선 (가톨릭의대) | |
| 16:55-17:10 | Big Data, Smartphone and AI in HF | 방재훈 (경희대학교 컴퓨터공학과) | |
| 17:10-17:25 | Will AI Doctor Replace Human Doctor? If Yes, When? | 최동주 (서울의대) | |
| 17:25-17:45 | Discussion | 경대성, 권준명 | |
| Room C | |||
|---|---|---|---|
| 12:05-12:55 | Scientific Session (III) - Samjin | 박대균 | |
| 12:05-12:25 | Atrial Fibrillation Patients with Heart Failure | 정혜문 (경희의대) | |
| 12:25-12:45 | Role of Apixaban in Patients with Heart Failure | ||
| 12:45-12:55 | Q&A | 손정우(연세원주의대) | |
| 13:00-14:20 | [Joint Session with KSCI and Surgery] Mitral Regurgitation |
채성철, 이상철 | |
| 13:00-13:15 | Anatomy and Physiology of the Mitral Valve and the Pathophysiology of Mitral Regurgitation | 박성지 (성균관의대) | |
| 13:15-13:30 | Why Did COAPT Win While MITRA-FR Failed? | 김중선 (연세의대) | |
| 13:30-13:45 | Role of Surgical Repair and Replacement in Secondary Mitral Regurgitation | 심지영 (연세의대) | |
| 13:45-14:00 | Step-by-Step Korean Mitral Clip Experiences and Its Future Perspectives | 강도윤 (울산의대) | |
| 14:00-14:20 | Discussion | 김희중, 이숙진 | |
| 14:20-15:00 | |||
| 15:00-16:20 | ABC's of the Genomics of Cardiomyopathy
(Tutorial Session) |
조명찬 | |
| 15:00-15:15 | Genome Analysis Strategies for Cardiomyopathies | 이승근 (서울대학교 데이터사이언스대학원) | |
| 15:30-16:00 | Interpretation of Cardiomyopathy Variants Identified by Targeted Sequencing | 신새암 (연세의대) | |
| 16:00-16:20 | Discussion | 김경진, 오재원, 이상언 | |
| 16:25-17:45 | [English Session] [Joint Session with HFA] Patient Reported Outcome (PRO) Research in HF |
Andrew Coats, Shung-Chull Chae | |
| 16:25-16:40 | What is PRO and How Can We Utilize It in HF Research? | Petar M. Seferović (Belgrade Univ., Serbia) |
|
| 16:40-16:55 | Real World HF Treatment Patterns and PRO in Korea | Byung-Su Yoo (Yonsei Wonju Univ., Korea) |
|
| 16:55-17:10 | Pitfalls of PRO Measurements: How to Overcome? | Giuseppe Rosano (Univ., of Catanzaro, Italy & St George’s Univ., UK) |
|
| 17:10-17:25 | Patch-type 12-lead ECG: Patient-generated ECG | Won-Chul Cha (Sungkyunkwan Univ., Korea) |
|
| 17:25-17:45 | Discussion | Jin-Bae Kim, Chan-Joo Lee | |
| Room D | ||
|---|---|---|
| 12:05-12:55 | Scientifc Session (IV) - Astrazeneca | 신동구 |
| 12:05-12:30 | See the Unseen; SGLT2 Inhibitors’ Potential Beyond Glucose Control | 김응주 (고려의대) |
| 12:30-12:55 | Connecting the dots; Role of Candesartan in Chronic Heart Failure | 김계훈 (전남의대) |
| Sep 26 (Sat), 2020 | |||
|---|---|---|---|
| Room A | |||
| 09:00-10:20 | [English Session] Cardiometabolic Disorders in HF (II) |
Sung-Kee Ryu (Korea) | |
| 09:00-09:15 | Diabetes and Cardiovascular Risk: Focus on HF | Giuseppe Rosano (Univ. of Catanzaro, Italy& St George’s Univ., UK) |
|
| 09:15-09:30 | Diabetes-Related Cardiomyopathy | Jah-Yeon Choi (Korea Univ., Korea) |
|
| 09:30-09:45 | Understanding the Mechanism of SGLT2 Inhibition in HF and Diabetes | Gerasimos Filippatos (National and Kapodistrian University, of Athens, Greece)) |
|
| 09:45-10:00 | GLP1 Receptor Agonists in Diabetes and HF: Mechanisms to Clinical Trials | Eun-Gyoung Hong (Hallym Univ., Korea) |
|
| 10:00-10:20 | Discussion | Sung-Hea Kim, Sun-Hwa Lee | |
| 10:20-11:00 | |||
| 11:00-12:20 | [Joint Session with KSIC] Optimal PCI in HF |
채인호, 김응주 | |
| 11:00-11:15 | Coronary Revascularization Strategies in Patients with Chronic HF | 윤창환 (서울의대) | |
| 11:15-11:30 | Optimal Timing of PCI for Multivessel Coronary Disease in Advanced HF | 양동헌 (경북의대) | |
| 11:30-11:45 | Role of CTO Intervention in Advanced HF Patients | 이승환 (울산의대) | |
| 11:45-12:00 | Optimization of PCI Strategy and New Medication Preventing Ischemic HF | 박상민 (을지의대) | |
| 12:00-12:20 | Discussion | 김계훈, 최윤석 | |
| 12:20-13:10 | Scientific Session (VI)- Merck & Daewoong | 유병수 | |
| 12:20-12:50 | Treatment of CHF with Beta-blockers | Erland Erdmann (Univ. of Cologne, Germany) |
|
| 12:50-13:10 | Discussion | ||
| 13:10-14:30 | Rare Myocardial Disease: Early Recognition and Treatment | 김동수 | |
| 13:10-13:25 | Anderson-Fabry Disease | 조익성 (연세의대) | |
| 13:25-13:40 | Glycogen Storage Disease | 황인창 (서울의대) | |
| 13:40-13:55 | Inflammatory Cardiomyopathies: Sarcoidosis | 김다래 (성균관의대) | |
| 13:55-14:10 | Mitochondrial Disease and MELAS Syndrome | 최홍미 (한림의대) | |
| 14:10-14:30 | Discussion | 김은경, 김형윤 | |
| 14:30-15:10 | |||
| 15:10-16:30 | AF and HF | 주승재 | |
| 15:10-15:15 | Introduction: A Crosstalk between Atrial Fibrillation and HF | ||
| 15:15-15:30 | Newly Diagnosed HF Patients with AF Should Receive Catheter Ablation: Pro | 심재민 (고려의대) | |
| 15:30-15:45 | Newly Diagnosed HF Patients with AF Should Receive Catheter Ablation: Con | 이상언 (울산의대) | |
| 15:45-15:50 | Newly Diagnosed HF Patients with AF Should Receive Catheter: Pro Rebuttal | 심재민 (고려의대) | |
| 15:50-15:55 | Newly Diagnosed HF Patients with AF Should Receive Catheter: Con Rebuttal | 이상언 (울산의대) | |
| 15:55-16:30 | Discussion | 유희태, 조현재 | |
| Room B | |||
|---|---|---|---|
| 09:00-10:20 | [Joint Session with Surgery and KSCI] Interventions for HF |
이명묵 | |
| 09:00-09:15 | Role of Extracorporeal Membrane Oxygenation (ECMO) Assistance during Percutaneous Coronary Intervention (PCI) in Severe Heart Failure (HF) | 최기홍 (성균관의대) | |
| 09:15-09:30 | Valve Intervention in HF due to VHD | 심지영 (연세의대) | |
| 09:30-09:45 | Benefits of CABG for Multivessel Coronary Disease with HF | 윤영남 (연세의대) | |
| 09:45-10:00 | Who Would Be the Best Candidates for Heart Transplantation? | 정성호 (울산의대) | |
| 10:00-10:20 | Discussion | 김민석, 최윤석 | |
| 10:20-11:00 | |||
| 11:00-12:20 | [English Session] Where Is the Correct Position of ARNI in HF? |
Byung-Hee Oh (Korea), Eui-Young Choi (Korea) |
|
| 11:00-11:15 | ARNI as a Upstream Treatment in HFrEF | Jee-Hoon Kang (Seoul National Univ., Korea) |
|
| 11:15-11:30 | ARNI in VHD (Reverse Remodeling) | Michael Böhm (Univ., of the Saarland in Homburg/Saar, Germany) |
|
| 11:30-11:45 | ARNI in Acute Decompensated HF | Andrew Coats (Monash Univ., Australia & Univ. of Warwick, UK) |
|
| 11:45-12:00 | ARNI in HFpEF - TBD | Carolyn Lam (Duke-NUS Medical School, Singapore) |
|
| 12:00-12:20 | Discussion | Hyun-Jai Cho, Hye-Moon Chung | |
| 12:20-13:10 | Scientific Session (VII)- Novartis | 최성훈 | |
| 12:20-12:45 | When is the Right Time to Reverse Cardiac Remodeling with ARNI? | 윤종찬 (가톨릭의대) | |
| 12:45-13:10 | Evidence-Based Optimisation of HFrEF Treatment before Discharge | 김경희 (세종병원) | |
| 13:10-14:30 | What's New in HF Pharmacological Therapy? | 백상홍 | |
| 13:10-13:25 | Vericiguat | 오재원 (연세의대) | |
| 13:25-13:40 | Omecamtiv | 손정우 (연세원주의대) | |
| 13:40-13:55 | Finerenone | 김현진 (한양의대) | |
| 13:55-14:10 | Potassium Binder | 정혜문 (경희의대) | |
| 14:10-14:30 | Discussion | 박상민, 김지희 | |
| 14:30-15:10 | |||
| 15:10-16:30 | RAS and HF : I'm Still Alive! | 정진옥 | |
| 15:10-15:25 | RAS in HF: Translational View | 조성우 (인제의대) | |
| 15:25-15:40 | Clinical Pearls in RAS Inhibition for HF | 최정현 (부산의대) | |
| 15:40-15:55 | Aldosterone Antagonist in HFpEF, Revival? | 김다래 (성균관의대) | |
| 15:55-16:10 | Post-PARAGON: Role of Sacubitril/ Valsartan in HF | 한성우 (한림의대) | |
| 16:10-16:30 | Discussion | 김형윤, 박진주 | |
| Room C | |||
|---|---|---|---|
| 09:00-10:20 | [English Session] HF; Are Women Different? |
Myung-A Kim (Korea) | |
| 09:00-09:15 | Sex Differences in Heart Failure: The Mars vs. Venus Story | Chanchal Chandramouli (NHCS, Singapore) |
|
| 09:15-09:30 | Menopause and HF | Hack-Lyoung Kim (Seoul National Univ., Korea) |
|
| 09:30-09:45 | Sex & Advanced HF Treatment: Are Women Being Left Out? | Jae-Hoon Chung (National Medical Center, Korea) |
|
| 09:45-10:00 | Pregnancy and HF | Sung-Ji Park (Sungkyunkwan Univ., Korea) |
|
| 10:00-10:20 | Discussion | Bong-Joon Kim, Mi-Hyang Jung | |
| 10:20-11:00 | |||
| 11:00-12:20 | [English Session] Cardiac Amyloidosis |
Dae-Gyun Park (Korea) | |
| 11:00-11:15 | Cardiac Amyloidosis: Diverse Clinical Presentation | Geu-Ru Hong (Yonsei Univ., Korea) |
|
| 11:15-11:30 | Cardiac Amyloidosis: Imaging and Biomarkers | Seung-Pyo Lee (Seoul National Univ., Korea) |
|
| 11:30-11:45 | Treatment of AL Amyloidosis | Mi-Seung Shin (Gachon Univ., Korea) |
|
| 11:45-12:00 | Recent Advances with Emphasis on ATTR | Jignesh K. Patel (Cedars-Sinai Smidt Heart Institute, US) |
|
| 12:00-12:20 | Discussion | Mi-Jeong Kim, Jong-Chan Youn | |
| 12:20-13:10 | Scientific Session (VIII)- Pfizer | 전은석 | |
| 12:20-12:50 | The Hidden Threat of ATTR-CM: Identification, Diagnosis, and Management | ||
| 12:50-13:10 | NOACs, NVAF, and Renal Impairment: What Do the Latest Data on Eliquis Suggest | 김봉준 (고신의대) | |
| 13:10-14:30 | Mechanical Circulatory Support | 최의영 | |
| 13:10-13:25 | ECMO Weaning Failure: Durable MCS vs. Heart Transplant | 조양현 (성균관의대) | |
| 13:25-13:40 | What Is the Future? Durable MCS vs. Heart Transplant | 김민석 (울산의대) | |
| 13:40-13:55 | Post-transplant Outcome of Sensitized MCS Patients | 윤종찬 (가톨릭의대) | |
| 13:55-14:10 | Performance Measures for MCS Program in National Heart Centre Singapore | David Sim (NHCS, Singapore) |
|
| 14:10-14:30 | Discussion | 윤현주, 이수용 | |
| 14:30-15:10 | |||
| 15:10-16:30 | [English Session] [Joint Session with ISHLT] Controversies and Advances in Heart Transplantation |
Eun-Seok Jeon (Korea), Jae-Joong Kim (Korea) |
|
| 15:10-15:25 | Expanding Donor Organ Recovery: A Global Perspective | Mandeep R Mehra (Brigham and Women's Hospital, US) |
|
| 15:25-15:40 | Optimizing the Donor Heart- Donor Management | Sung-Ho Jung (Ulsan Univ., Korea) |
|
| 15:40-15:55 | Decreasing Waitlist Mortality: Expanded Donors and Prioritized Candidates | Kiran Kaur Khush (Stanford Univ., US) |
|
| 15:55-16:10 | Immunosuppressive Regimens to Delay Transplantopathy | Kyung-Hee Kim (Mediplex Sejong Hospita, Korea) |
|
| 16:10-16:30 | Discussion | Jong-Chan Youn | |
| Room D | |||
|---|---|---|---|
| 09:00-10:00 | Recent Trlals and Researches | 홍석근 | |
| 09:00-09:15 | Cardiovascular and Renal Outcomes with Empagliflozin in HF | 최정현 (부산의대) | |
| 09:15-09:30 | Vericiguat in Patients with HFrEF | 정진옥 (충남의대) | |
| 09:30-09:45 | Cholchicine in Patients with Chronic Coronary Disease | 조상호 (한림의대) | |
| 09:45-10:00 | Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 | 김인철 (계명의대) | |
| 11:00-11:50 | Scientific Session (V)- Daewoong & Daiichisankyo | 김영대 | |
| 11:00-11:25 | Heart Failure and Atrial Fibrillation | 최진오 (성균관의대) | |
| 11:25-11:50 | Hot Issues in NOACs: Efficacy and Safety of Low Dose NOACs | 이소령 (서울의대) | |
| 12:20-13:10 | Scientific Session (IX)- Boehringer Ingelheim & Lilly | 양동헌 | |
| 12:20-12:50 | Heart Failure, Further Risk Management for the Patient with Type 2 Diabetes | Gerasimos Filippatos (National and Kapodistrian University, of Athens, Greece)) |
|
| 12:50-13:10 | Taking the initiatives of SGLT2i; Wait and see or move NOW? | 박진주 (서울의대) | |
| 13:10-14:30 | KSHF Academy Session I: 심부전 쉽게 알기 | 한성우 | |
| 13:10-13:25 | 심부전이란? | 서석민 (가톨릭의대) | |
| 13:25-13:40 | 심부전의 비약물치료 | 조은정 (한림의대) | |
| 13:40-13:55 | 심부전의 약물치료 | 조동혁 (연세원주의대) | |
| 13:55-14:10 | 심부전의 수술적치료 | 최효인 (성균관의대) | |
| 14:10-14:30 | Discussion | 안효석, 조정선 | |
| 14:30-15:10 | |||
| 15:10-16:30 | KSHF Academy Session II: 간호, 재활 | 임세중, 김현주 | |
| 15:10-15:25 | 말기 심부전 환자를 위한 호스피스 치료 | 옥종선 (건국대학교 간호학과) | |
| 15:25-15:40 | 재입원 방지를 위한 환자와 보호자 점검 사항 및 교육 팁 | 이경은 (세브란스병원) | |
| 15:40-15:55 | 심장이식 및 좌심실 보조장치 환자의 외래 관리 | 박은경 (한림대학교 동탄성심병원) | |
| 15:55-16:10 | 심부전 환자의 지속적인 재활을 위한 운동방법 및 교육 팁 | 장윤아 (고려대학교 구로병원) | |
| 16:10-16:30 | Discussion | 손연정, 정인현 | |
| Sep 27 (Sun), 2020 | |||
|---|---|---|---|
| Room A | |||
| 09:00-10:20 | Cardio-Oncology in Asia | 김계훈, 윤호중 | |
| 09:00-09:15 | Cardiotoxic Drugs and HF | 김지희 (가톨릭의대) | |
| 09:15-09:30 | Cardio-Oncology in Asia: Epidemiology | 정미향 (한림의대) | |
| 09:30-09:45 | Treatment of Cardiotoxicity: New Frontiers | 김은경 (성균관의대) | |
| 09:45-10:00 | How to Develop a Cardio-Oncology Clinic | 정우백 (가톨릭의대) | |
| 10:00-10:20 | Discussion | 김재경, 박혁진 | |
| 10:20-10:30 | |||
| 10:30-11:50 | [English Session] [Joint Session with CHFA] HF Epidemiology |
Dae-Gyun Park (Korea) | |
| 10:30-10:45 | HF Pandemic in Asia | Jian Zhang (Fuwai Hospital, China) |
|
| 10:45-11:00 | Hypertension and HF | Eung-Ju Kim (Korea Univ., Korea) |
|
| 11:00-11:15 | DM and HF | Yuhui Zhang (Fuwai Hospital, China) |
|
| 11:15-11:30 | Epidemiologic Perspectives to Prevent and Control HF | Hyeon-Chang Kim (Yonsei Univ., Korea) |
|
| 11:30-11:50 | Discussion | Young-Sup Byun, Eun-Jeong Cho | |
| Room B | |||
|---|---|---|---|
| 09:00-10:20 | [English Session] [Joint Session with JHFS] How to Establish a Good LVAD Program |
Seok-Min Kang (Korea), Sung-Woo Han (Korea) |
|
| 09:00-09:15 | Patient Selection for LVAD: Who Is the Good Candidate? | Koichiro Kinugawa (Univ., of Toyama, Japan) |
|
| 09:15-09:30 | Surgical Pitfalls in LVAD Surgery | Woo Sung Jang (Keimyung Univ., Korea) |
|
| 09:30-09:45 | Medical Pitfalls in Post-LVAD Care | Minoru Ono (Univ., of Tokyo, Japan) |
|
| 09:45-10:00 | When and Whom Should Be Transplanted? | Jin-Oh Choi (Sungkyunkwan Univ., Korea) |
|
| 10:00-10:20 | Discussion | Jin Wi, Jae-Hyuk Choi | |
| 10:20-10:30 | |||
| 10:30-11:50 | Practical Tips for LVAD | 홍석근 | |
| 10:30-10:45 | Introduction of LVAD System in Korea - How to Organize LVAD Program? | 김인철 (계명의대) | |
| 10:45-11:00 | Patient Selection and Pre-LVAD Management | 이선기 (한림의대) | |
| 11:00-11:15 | Device Selection for Left Ventricular Assist: Which One? | 조양현 (성균관의대) | |
| 11:15-11:30 | Common Complications after LVAD and Their Solutions | 김민석 (울산의대) | |
| 11:30-11:50 | Discussion | 박재형, 정성호 | |
| Room C | |||
|---|---|---|---|
| 09:00-10:20 | [Joint Session with KSE] Right-Side HF, Not Old |
신미승 | |
| 09:00-09:15 | Medical vs. Surgical Tx of Secondary TR: Current Guidance | 김미나 (고려의대) | |
| 09:15-09:30 | Isolated TR: Is it Different from Secondary TR? | 박재형 (충남의대) | |
| 09:30-09:45 | Medically Reversible Severe TR | 조인정 (이화의대) | |
| 09:45-10:00 | Postoperative Management of RHF after TV Surgery | 김동중 (서울의대 흉부외과) | |
| 10:00-10:20 | Discussion | 김성은, 조은정 | |
| 10:20-10:30 | |||
| 10:30-11:50 | Pulmonary Hypertension and HF | 정욱진 | |
| 10:30-10:45 | Why PH Is Important in HF Patients? | 김현진 (한양의대) | |
| 10:45-11:00 | How to Classify PH-LHD (Group 2 PH)? | 손정우 (연세원주의대) | |
| 11:00-11:15 | How to Treat PH-LHD? | 정욱진 (가천의대) | |
| 11:15-11:30 | PH in LVAD & HTPL | 장영우 (가천의대) | |
| 11:30-11:50 | Discussion | 서혜선, 황희정 | |
| Room D | |||
|---|---|---|---|
| 09:00-10:20 | 입원전담전문의, 현재와 미래 | 김성해, 신동호 | |
| 09:00-09:15 | 입원전담전문의 제도의 배경과 현황 | 김낙현 (서울의대) | |
| 09:15-09:30 | 심부전 Specialist가 바라보는 입원전담전문의 | 최성훈 (한림의대) | |
| 09:30-09:45 | 입원전담전문의가 보는 심부전 환자 Dilemma | 김은선 (서울의대) | |
| 09:45-10:00 | 급성 심부전 환자를 위한 Practical Tip | 최정현 (부산의대) | |
| 10:00-10:20 | Discussion | 김준환, 김경진, 정혜문 | |
| 10:20-10:30 | |||
| 10:30-11:50 | KSHF Academy Session III: Case Based Learning | 김재중, 신준한 | |
| 10:30-10:45 | Take 1. HF Management at ER - Typical ADHF Management (Patient with Cardiogenic Shock or ADHF) |
김봉준 (고신의대) | |
| 10:45-11:00 | Take 2. HF Management at ICU - Setting and Managements of Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock |
양정훈 (성균관의대) | |
| 11:00-11:15 | Take 3. HF Management at General Ward - Focusing on Education, Drug Dosing |
이찬주 (연세의대) | |
| 11:15-11:30 | Take 4. HF Management at OPD - When You Escalate or Descalate HF Drugs, Other Possible Options |
조동혁 (연세원주의대) | |
| 11:30-11:50 | Discussion | 김동수, 김명아 | |
- Scientific
Program